DB1:XETRDeutsche Boerse AG Analysis
Data as of 2026-05-24 - not real-time
€256.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Deutsche Börse AG (DB1.DE) is trading at €256, comfortably above its 20‑day (≈€255.15) and 50‑day (≈€252.52) simple moving averages and the 200‑day SMA (≈€232.66), confirming a bullish trend. The MACD histogram is positive (≈0.29) and the MACD line sits above the signal line, while the RSI sits at a neutral 53, indicating room for further upside without immediate overbought pressure. Fundamentals remain robust with an 8.5% revenue growth, operating margins above 40%, and a solid ROE of ~19%, though the trailing PE of ~22.8 is notably higher than the industry average of ~16.8, suggesting a premium valuation. The dividend yield of 1.64% is backed by a modest payout ratio of ~36%, supporting sustainability.
Market sentiment is extremely bullish (Fear‑Greed Index 91.6) and analysts collectively rate the stock as a “buy” with a median target of €293, implying ~12% upside. The recent listing of the Virtune Hyperliquid ETP on Xetra adds a new crypto‑asset revenue stream, reinforcing the exchange’s diversification and growth narrative.
Market sentiment is extremely bullish (Fear‑Greed Index 91.6) and analysts collectively rate the stock as a “buy” with a median target of €293, implying ~12% upside. The recent listing of the Virtune Hyperliquid ETP on Xetra adds a new crypto‑asset revenue stream, reinforcing the exchange’s diversification and growth narrative.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish technical setup (price above SMA20/50, positive MACD)
- Neutral RSI indicating upside potential
- Positive crypto‑asset listing expanding revenue sources
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong earnings growth and high operating margins
- Target price upside of ~12% and favorable analyst consensus
- Sustainable dividend with low payout ratio
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Stable cash flow generation and solid ROE
- Premium valuation relative to peers requiring careful monitoring
- Regulatory environment and diversification into digital assets
Key Metrics & Analysis
Financial Health
Revenue Growth8.50%
Profit Margin27.26%
P/E Ratio22.8
ROE19.20%
ROA0.65%
Debt/Equity65.44
P/B Ratio4.4
Industry P/E16.8
Technical Analysis
TrendBullish
RSI53.4
Support€240.80
Resistance€269.60
MA 20€255.15
MA 50€252.52
MA 200€232.66
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
Target Price€287.92
Upside/Downside12.47%
GradeFair
TypeBlend
Dividend Yield1.64%
Risk Assessment
Beta-0.20
Volatility21.76%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.